Live Breaking News & Updates on New experimental drug

Innovative study on mice leads to a potential targeted monoclonal antibody therapy to manage Type I diabetes. Study highlights need for human version of antibody.

United-states , American , Devi-kasinathan , Zheng-guo , Dax-fu , Johns-hopkins-university-school-of-medicine , Surface-znt , Reverses-autoimmune-diabetes , Johns-hopkins-medicine , Drug-shelters-pancreas-cells , Immune-system , New-experimental-drug